Calidi Biotherapeutics PEG Ratio

Calidi Biotherapeutics (CLDI) currently reports a PEG ratio of 0.17. That is above the sector sector average of -7.59. Use the charts on this page to explore Calidi Biotherapeutics's PEG ratio history and peer comparisons.

Calidi Biotherapeutics's PEG ratio of 0.17 is higher than the its sector sector average of -7.59. That is roughly 102.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Calidi Biotherapeutics's market price to a fundamental measure such as earnings, sales, or book value. At 0.17, CLDI can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 0.17, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -7.59. From there, open related valuation or income-statement pages for Calidi Biotherapeutics, and consider following CLDI for alerts when major investors trade the stock.